As shown in Figures 4D–F, the mRNA levels of Mfn1, mitofusin 2 (Mfn2), and Opa1 were significantly lower in the hyperglycemia group than in the control group; however, matrine attenuated this reduction. The gene discussed is MFN2; the disease is Hyperglycemia.